Description
BPA PHARMACEUTICAL COMPOUNDING
First action · last action
2019-12-09 · 2021-08-26
Transactions
2
First transaction's obligation
$275,050
Base + all options value (sum of deltas)
$2,603,803
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
36C26120A0008
NAICS
446110 · PHARMACIES AND DRUG STORES
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-12-09+$275,050= $275,050
- Mod P000022021-08-26-$41,803= $233,247
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-12-09 | +$275,050 | $275,050 | BPA PHARMACEUTICAL COMPOUNDING |
| Mod P00002· FUNDING ONLY ACTION | 2021-08-26 | −$41,803 | $233,247 | BPA PHARMACEUTICAL COMPOUNDING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI K5MHR9JB9ND5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0168 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q517 · PHARMACY SERVICES | $0 | FY2026 |
| 36C26126P0374 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $156,000 | FY2026 |
| 36C24226N0311 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $200,000 | FY2026 |
| 36C24226N0309 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $269,557 | FY2026 |
| 36C26026N0063 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q517 · PHARMACY SERVICES | $557 | FY2026 |
| 36C24226N0127 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $20,584 | FY2026 |
Other recipients under Q517 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P0986 | L1 ENTERPRISES INCORPORATED | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $44,920 | FY2026 |
| 36C26126P0904 | UNITED RETURNS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $18,000 | FY2026 |
| 36C26126N0541 | PALISADE-HERITAGE JV LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $300,000 | FY2026 |
| 36C26126P0822 | PHARMALINK INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $11,750 | FY2026 |
| 36C26126P0561 | PHARMALINK INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $36,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26120N0279_3600_36C26120A0008_3600 · retrieved 2026-09-26.